BMS-986165 (Deucravacitinib) Combination Database

Jump to:

• BMS-986165 (Deucravacitinib) Mechanism of Action: TYK2 Inhibition in Immune Cell Research
• BMS-986165 (Deucravacitinib) Working Concentration | Cell Culture | Treatment
• BMS-986165 (Deucravacitinib) Solubility in DMSO
• BMS-986165 (Deucravacitinib) Storage & Stability
• BMS-986165 (Deucravacitinib) Molecular Weight | Chemical Structure | Stock Solution
• BMS-986165 (Deucravacitinib) IC50 for Cell-based and Cell-free Assays
• BMS-986165 (Deucravacitinib) Cayman (33524)? Try a better option.
• BMS-986165 (Deucravacitinib) MCE (HY-117287)? Try a better option.
• BMS-986165 (Deucravacitinib) Abmole (M4138)? Try a better option.
• BMS-986165 (Deucravacitinib) AdooQ (A18726)? Try a better option.
• BMS-986165 (Deucravacitinib) TargetMol (T14687)? Try a better option.
• BMS-986165 (Deucravacitinib) SDS｜MSDS
• BMS-986165 (Deucravacitinib) in Psoriatic Arthritis
• BMS-986165 (Deucravacitinib) in Systemic Lupus Erythematosus
• BMS-986165 (Deucravacitinib) in Inflammatory Bowel Disease